Something is changing about how great pharma campaigns get made. Not who makes them. How they scale. AI has unlocked a level of personalization that simply wasn't realistic before. The same core story, adapted for an HCP in oncology, a caregiver managing a rare disease, a patient hearing a diagnosis for the first time. Each version speaks directly to where that person is. Not a different campaign — the same idea, made relevant to the right person at the right moment. That changes the creative conversation entirely. When you can test ten versions as easily as one, bold ideas stop feeling like a gamble. When content adapts in hours instead of weeks, teams spend less time waiting and more time learning what actually lands. The opportunity isn't to produce more. It's to say the right thing to the right person, faster than ever before. That's where the real ROI is.
Read post →Thoughts
Posts
If you strip the logos off 90% of healthcare ads, they look exactly the same. The same smiling couples walking on beaches. The same sterile, clinical animations. It just becomes digital wallpaper. That's a massive problem. When the visuals are boring, brilliant science gets ignored. Incredible breakthroughs get scrolled right past simply because the creativity didn't command attention. I've always believed that science is inherently creative. It shouldn't be hidden behind dry, predictable marketing. My goal is to change that; to turn complex biotech into creative stories that actually make people stop and feel something. If you're also thinking about how we can change biotech advertising and want to do things differently, I'd love to connect. Drop me a message, let's just chat and share some ideas.
Read post →